Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Scarr

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
The International Journal of Neuropsychopharmacology|February 18, 2012
Widespread decreases in cortical muscarinic receptors in a subset of people with schizophreniaAndrew Stuart Gibbons, Elizabeth Scarr, Simone Boer, et al.
Brain Research|November 23, 2006
Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorderRobert E McCullumsmith, Lars V Kristiansen, Monica Beneyto, et al.
The International Journal of Neuropsychopharmacology|February 6, 2014
Lower cortical serotonin 2A receptors in major depressive disorder, suicide and in rats after administration of imipramineBrian Dean, Nahed Tawadros, Myoung Suk Seo, et al.
Psychiatry Research|February 27, 2021
Cortical expression of the RAPGEF1 gene in schizophrenia: investigating regional differences and suicideAndrea Gogos, Jeehae Sun, Madhara Udawela, et al.
The Australian and New Zealand Journal of Psychiatry|July 16, 2008
Regulator of G-protein signalling 4 expression is not altered in the prefrontal cortex in schizophreniaAndrew Stuart Gibbons, Elizabeth Scarr, Caitlin E McOmish, et al.
The International Journal of Neuropsychopharmacology|July 28, 2011
Nicotinamide-N-methyltransferase (NNMT) in schizophrenia: genetic association and decreased frontal cortex mRNA levelsAnna Bromberg, Elad Lerer, Madhara Udawela, et al.
The Australian and New Zealand Journal of Psychiatry|May 28, 2015
Changes in cortical N-methyl-D-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicideBrian Dean, Andrew S Gibbons, Simone Boer, et al.
The International Journal of Neuropsychopharmacology|September 26, 2013
Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think TankBrian Dean, Hans-Jürgen Moller, Torgny H Svensson, et al.
The International Journal of Neuropsychopharmacology|April 23, 2015
Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think TankElizabeth Scarr, Mark J Millan, Sabine Bahn, et al.
The International Journal of Neuropsychopharmacology|August 8, 2007
Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophreniaShirly Amar, Galit Shaltiel, Liad Mann, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
The International Journal of Neuropsychopharmacology|February 18, 2012
Widespread decreases in cortical muscarinic receptors in a subset of people with schizophreniaAndrew Stuart Gibbons, Elizabeth Scarr, Simone Boer, et al.
Brain Research|November 23, 2006
Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorderRobert E McCullumsmith, Lars V Kristiansen, Monica Beneyto, et al.
The International Journal of Neuropsychopharmacology|February 6, 2014
Lower cortical serotonin 2A receptors in major depressive disorder, suicide and in rats after administration of imipramineBrian Dean, Nahed Tawadros, Myoung Suk Seo, et al.
Psychiatry Research|February 27, 2021
Cortical expression of the RAPGEF1 gene in schizophrenia: investigating regional differences and suicideAndrea Gogos, Jeehae Sun, Madhara Udawela, et al.
The Australian and New Zealand Journal of Psychiatry|July 16, 2008
Regulator of G-protein signalling 4 expression is not altered in the prefrontal cortex in schizophreniaAndrew Stuart Gibbons, Elizabeth Scarr, Caitlin E McOmish, et al.
The International Journal of Neuropsychopharmacology|July 28, 2011
Nicotinamide-N-methyltransferase (NNMT) in schizophrenia: genetic association and decreased frontal cortex mRNA levelsAnna Bromberg, Elad Lerer, Madhara Udawela, et al.
The Australian and New Zealand Journal of Psychiatry|May 28, 2015
Changes in cortical N-methyl-D-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicideBrian Dean, Andrew S Gibbons, Simone Boer, et al.
The International Journal of Neuropsychopharmacology|September 26, 2013
Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think TankBrian Dean, Hans-Jürgen Moller, Torgny H Svensson, et al.
The International Journal of Neuropsychopharmacology|April 23, 2015
Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think TankElizabeth Scarr, Mark J Millan, Sabine Bahn, et al.
The International Journal of Neuropsychopharmacology|August 8, 2007
Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophreniaShirly Amar, Galit Shaltiel, Liad Mann, et al.
Pageof 10